AdelZ.MakaryMD

PubMed

• 2 citations
  Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III r...
  Selina M. Luger, Victoria Wang, Jacob M. Rowe, Mark R. Litzow, Elisabeth Paietta, Rhett P. Ketterling, Hillard M. Lazarus, Witold B. Rybka, Michael Craig, Judith E. Ka...> ;Leukemia Research. 2021 Oct 28
• 19 citations
  Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid
  James R. Berenson, Ori Yellin, John Crowley, Adel Z. Makary, Donald S. Gravenor, Hank H. Yang, Gargi Upadhyaya, Ian W. Flinn, Harry Staszewski, Natasha M. Tiffany, Sha...> ;American Journal of Hematology. 2011 Jan 1
• Factors that determine survival among patients with multiple myeloma (MM) treated with zoledronic acid (ZOL).
  Yellin O, Crowley J, Swift RA, Makary A, Gravenor DS, Yang HH, Upadhyaya GH, Flinn IW, Staszewski H, Tiffany NM, Berenson JR> ;J. Clin. Oncol.. 2009-05-20
• 7 citations
  Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: A study of the Eastern Cooperative Oncology Grou...
  Janice P. Dutcher, Sandra J. Lee, Robert E. Gallagher, Adel Z. Makary, J. D. Hines, Harold Londer, John P. Farnen, John M. Bennett, Elisabeth Paietta, Jacob M. Rowe, O...> ;Leukemia & Lymphoma. 2005 Mar 1
• 220 citations
  A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group
  Jacob M. Rowe, Donna Neuberg, William R. Friedenberg, John M. Bennett, Elisabeth Paietta, Adel Z. Makary, Jane L. Liesveld, Camille N. Abboud, Gordon W. Dewald, F. Ann...> ;Blood. 2004 Jan 15
• 68 citations
  Transmission of a T-cell lymphoma by allogeneic bone marrow transplantation.
  Karin D. Berg, Nooshin K. Brinster, Karen M. Huhn, Michael Goggins, Richard J. Jones, Adel Makary, Kathleen M. Murphy, Constance A. Griffin, Lynne S. Rosenblum-Vos, Mi...> ;The New England Journal of Medicine. 2001 Nov 15
• 45 citations
  Plasmapheresis. A therapeutic option in the management of heparin-associated thrombocytopenia with thrombosis.
  James O. Brady, John A. Riccio, Omar Yumen, Adel Z. Makary, Steven M. Greenwood> ;American Journal of Clinical Pathology. 1991 Sep 1
• 17 citations
  Chronic Lymphocytic Leukemia (CLL) Terminating in Multiple Myeloma: Report of Two Cases
  Robert H. Kough, Adel Z. Makary> ;Blood. 1978 Sep 1
• 2 citations
  Erythroid variant of chronic myelogenous leukemia
  N Talreja, Haifaa Abdulhaq, Richard K. Shadduck, James M. Rossetti, A Jalil, A Makary, John Lister> ;Leukemia. 2008 Apr 1
• Sensorineural hearing loss after general anaesthesia.
  Naesh, O., Gilbert, J., Makary, A.> ;Anaesth Intensive Care. 2005 Aug
• Potential markers of the atherosclerotic process in high-risk children.
  Szamosi, T., Mihai, K., Peto, J., Makary, A., Kramer, J.> ;Clin Biochem. 1991 Apr
• Chronic neutrophilic leukemia evolving from a myelodysplastic syndrome.
  Pascucci, M., Dorion, P., Makary, A., Froberg, M. K.> ;Acta Haematol. 1997
• A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group.
  Dutcher, J. P., Leong, T., Makary, A. Z., Bennett, J., Frontiera, M., Miller, H., Wiernik, P. H.> ;Leukemia. 1995 Oct
• Thrombotic thrombocytopenic purpura.
  Makary, A. Z., Kough, R. H.> ;Pa Med. 1983 Sep
• Apparent death with accidental hypothermia. A case report.
  Edwards, H. A., Benstead, J. G., Brown, K., Makary, A. Z., Menon, N. K.> ;Br J Anaesth. 1970 Oct
• The activated partial thromboplastin time as a monitor of heparin therapy: a warning.
  Makary, A. Z., Waterbury, L.> ;Johns Hopkins Med J. 1977 Jun
• Case report. Effect of antineoplastic chemotherapy on cervical cytology.
  Nelson, J., Makary, A. Z., Kough, R. H.> ;Pa Med. 1979 May
• Join now to see all